# Exjade

NDC: 0078-0468
Generic name: deferasirox
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20051130

FDA application: NDA021882

## Active ingredients

- DEFERASIROX: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0468"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0468
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a70c-870c-4968-940e-8baea152cf85